Public Advisory - Sivem ezetimibe 10 mg tablets: One lot recalled as some bottles may contain perindopril 4 mg tablets Français
Issue: Health products – Product safety
What to do: If your bottle of ezetimibe 10 mg tablets contains any perindopril 4 mg tablets, or if you are unsure, return it to your pharmacy immediately. If you are unable to return your tablets to the pharmacy right away, talk to your pharmacist or doctor for further guidance. Seek immediate medical attention if you are experiencing serious side effects, including symptoms of a severe allergic reaction, such as difficulty breathing or swallowing or severe swelling of the lips, mouth or throat.
Affected products
Issue
Sivem Pharmaceuticals ULC is recalling one lot of Sivem ezetimibe 10 mg tablets because some bottles may also contain perindopril 4 mg tablets. Taking perindopril when prescribed ezetimibe may pose serious health risks.
Ezetimibe is a prescription drug used by adults and children 10 years of age and older to lower cholesterol and other fats in the blood. Perindopril is a prescription drug used in adults to treat high blood pressure.
Patients not normally prescribed perindopril may experience side effects such as a drop in blood pressure, dizziness, light-headedness or fainting. Other possible effects could include headache, cough, or gastrointestinal discomfort (e.g., nausea, vomiting or diarrhea). The risk can be higher in people with low blood pressure, kidney problems, or those taking other medications that affect blood pressure. Patients unknowingly taking a medication could also have a severe allergic reaction to that medication.
Health Canada is monitoring the company's recall and investigation, including its implementation of corrective and preventive actions to prevent this issue from reoccurring. The Department will inform the public if any new health risks are identified.
What you should do
Check your medication bottle to ensure it only contains Sivem ezetimibe 10 mg tablets.
Sivem ezetimibe 10 mg is a white oblong tablet, with "93" stamped on one side and "A11" on the other.
Perindopril 4 mg is a spotted light green oblong tablet, with "4" stamped on one side and nothing stamped on the other. The tablet is scored (indented) on both middle edges.
If the bottle contains any unusual tablets, or if you are unsure, return it to your pharmacy immediately. Your pharmacist will check the tablets and provide you with a replacement, if needed.
If you are unable to return your tablets to the pharmacy right away, talk to your pharmacist or doctor for further guidance.
Seek immediate medical attention if you are experiencing serious side effects (e.g., dizziness, light-headedness or fainting, or severe allergic reaction).
If you have questions about this recall, contact Sivem Pharmaceuticals by calling 1-855-757-4836 or by emailing [email protected].
Report any health product-related side effects or complaints to Health Canada.
Additional information for health professionals:
Health care professionals, such as pharmacists, should check bottles of Sivem ezetimibe 10 mg tablets before dispensing to ensure they do not contain perindopril 4 mg tablets. Report any unusual bottles or other issues to the company and to Health Canada.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Calgary Herald
4 days ago
- Calgary Herald
Opinion: Pharmacist advocates for easier access to Health Canada-approved nicotine pouch
Article content As a pharmacist, I take my individual patients' health seriously. I've dedicated my career to helping people make safer, healthier choices. Lately, I've felt the need to speak up, not just as a health-care professional, but as someone who works directly with smokers trying — often desperately — to quit. Article content Last week, Manitoba pharmacists were quoted in a media article saying no pharmacist is feeling frustrated that people must access the only Health Canada-approved NRT nicotine pouch (ZONNIC) from pharmacists. Article content Article content Article content That doesn't reflect my sentiment, or that of many of my colleagues. Many pharmacists don't understand or agree with the federal ministerial order that singled out the only Health Canada-approved nicotine pouch, requiring it to be sold only by a pharmacist from behind the counter. Article content Article content ZONNIC is a legitimate stop-smoking product. It's approved by Health Canada as a nicotine replacement therapy, just like gums, lozenges and patches. It contains the same ingredient — nicotine — used to reduce cravings and feelings of withdrawal when a person cuts back or stops smoking. Most people attempt to quit smoking several times before they are successful. Having a wider range of NRT products available means people who smoke have more options to help them quit. Article content Widespread availability of a variety of NRT products is also crucial to achieving Canada's tobacco strategy (five per cent or less of the population smoking by the year 2035). Article content Article content As pharmacists, we understand that new and innovative products need to be adequately researched and tested before being offered for sale to the public. The nicotine pouch ZONNIC met all the clinical and regulatory requirements for it to be classified as a natural health product. It is much safer than any other nicotine pouch, as it is the only one that has been through the regulatory approval process with Health Canada. Article content All other nicotine pouches are illegal products, many of them being sold in higher strengths, youth-attractive packaging and flavours, and with no oversight on ingredients or age verification. These potentially dangerous, unregulated nicotine pouches are easier to purchase than the legally approved ones, and that isn't right. Article content Limiting access to regulated products has unintended consequences. It encourages people to seek out unregulated products that may not be properly age-verified and have not been vetted by Health Canada.
CBC
4 days ago
- CBC
Extreme heat expected for eastern Ontario this weekend
Environment Canada has issued another heat warning for eastern Ontario as temperatures are expected to rise to the low 30s this weekend. The weather agency said the heat wave will begin Saturday with daytime highs between 30 and 33 C, potentially feeling as hot as 40 C with humidity. There'll be no break from the heat after sunset either, as overnight lows range from 19 to 23 C. The heat wave is expected to end with cooler temperatures midway through next week. This is the fourth heat warning Environment Canada has issued for Ottawa this summer, with the most recent one coming two weeks ago when temperatures were in the low-to-mid 30s in Ottawa-Gatineau. Heat can affect everyone Environment Canada warns that extreme heat can affect everyone's health and encourages anyone suffering from heat exhaustion to stop physical activities and drink water. Red and hot skin, dizziness, nausea, confusion and change in consciousness are possible signs of heat stroke, according to the agency. Health Canada recommends staying cool and staying hydrated when extreme heat hits. That can mean everything from drinking lots of water and rescheduling outdoor activities for cooler times to preparing meals that don't require ovens and keeping track of nearby air-conditioned spaces. Anyone who feels they have heat stroke should call 911. public and other places to cool off.
Global News
4 days ago
- Global News
These heated socks are being recalled due to potential burns, blisters
Health Canada is warning Canadians that various Fieldsheer branded heated socks have been recalled over concerns the products could potentially cause blisters or burns. The Merino wool-heated sock and Premium 2.0 Merino heated sock are affected, but so is a different version of the Premium 2.0 that is sold with a 'differing mechanism for holding the battery unit.' The second premium unit either uses a zipper or a slit for the battery. The heated socks, the recall says, may cause burns and/or blisters on consumers' feet through a possible combination of heat, excessive friction, moisture and pressure. As of July 29, there have been 19 reports of incidents in Canada and one reported injury. The U.S. has also reported 10 incidents and one injury. View image in full screen A list of the products and model numbers of various Fieldsheer branded heated socks recalled due to potential blister and burn hazards. Health Canada The recall was issued by Health Canada, the U.S. Consumer Product Safety Commission and Fieldsheer Apparel Technologies. Story continues below advertisement Fieldsheer says between August 2021 and June 2025 a total of 26,492 units of the affected socks were sold in Canada, with another 45,046 sold in the U.S. Get weekly health news Receive the latest medical news and health information delivered to you every Sunday. Sign up for weekly health newsletter Sign Up By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy Those who have purchased the socks are urged to immediately stop using the recalled products and contact Fieldsheer for a refund or replacement. It added the included lithium-ion battery packs should be disposed of according to local municipal hazardous waste guidelines. One of the pairs of Fieldsheer branded heated socks that have been recalled due to potential blister and burn hazards. Health Canada
